» Articles » PMID: 10024247

Reciprocal Control of T Helper Cell and Dendritic Cell Differentiation

Overview
Journal Science
Specialty Science
Date 1999 Feb 19
PMID 10024247
Citations 359
Authors
Affiliations
Soon will be listed here.
Abstract

It is not known whether subsets of dendritic cells provide different cytokine microenvironments that determine the differentiation of either type-1 T helper (TH1) or TH2 cells. Human monocyte (pDC1)-derived dendritic cells (DC1) were found to induce TH1 differentiation, whereas dendritic cells (DC2) derived from CD4+CD3-CD11c- plasmacytoid cells (pDC2) induced TH2 differentiation by use of a mechanism unaffected by interleukin-4 (IL-4) or IL-12. The TH2 cytokine IL-4 enhanced DC1 maturation and killed pDC2, an effect potentiated by IL-10 but blocked by CD40 ligand and interferon-gamma. Thus, a negative feedback loop from the mature T helper cells may selectively inhibit prolonged TH1 or TH2 responses by regulating survival of the appropriate dendritic cell subset.

Citing Articles

Blastic Plasmacytoid Dendritic Cell Neoplasm, from a Dermatological Point of View.

Di Raimondo C, Lozzi F, Di Domenico P, Paganini C, Campione E, Galluzzo M Int J Mol Sci. 2024; 25(13).

PMID: 39000208 PMC: 11240932. DOI: 10.3390/ijms25137099.


Dendritic Cells: A Bridge between Tolerance Induction and Cancer Development in Transplantation Setting.

Troise D, Infante B, Mercuri S, Catalano V, Ranieri E, Stallone G Biomedicines. 2024; 12(6).

PMID: 38927447 PMC: 11200833. DOI: 10.3390/biomedicines12061240.


LTX-315 triggers anticancer immunity by inducing MyD88-dependent maturation of dendritic cells.

Li X, Yamazaki T, He T, Alam M, Liu J, Trivett A Front Immunol. 2024; 15:1332922.

PMID: 38545099 PMC: 10967226. DOI: 10.3389/fimmu.2024.1332922.


Plasmacytoid dendritic cells: A dendritic cell in disguise.

Arroyo Hornero R, Idoyaga J Mol Immunol. 2023; 159:38-45.

PMID: 37269733 PMC: 10625168. DOI: 10.1016/j.molimm.2023.05.007.


Canvassing Prospects of Glyco-Nanovaccines for Developing Cross-Presentation Mediated Anti-Tumor Immunotherapy.

Makandar A, Jain M, Yuba E, Sethi G, Gupta R Vaccines (Basel). 2022; 10(12).

PMID: 36560459 PMC: 9784904. DOI: 10.3390/vaccines10122049.